Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.888
+0.069 (8.39%)
At close: Mar 6, 2026, 4:00 PM EST
0.910
+0.022 (2.48%)
After-hours: Mar 6, 2026, 7:59 PM EST
Tenaya Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Tenaya Therapeutics stock have an average target of 5.25, with a low estimate of 3.00 and a high estimate of 8.00. The average target predicts an increase of 491.22% from the current stock price of 0.89.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 18, 2025.
Analyst Ratings
The average analyst rating for Tenaya Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +463.06% | Dec 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +237.84% | Dec 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +800.90% | Dec 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +913.51% | Nov 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +463.06% | Sep 2, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.62
from -1.31
EPS Next Year
-0.47
from -0.62
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.55 | -0.37 | ||||
| Avg | -0.62 | -0.47 | ||||
| Low | -0.74 | -0.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.